Wendy L. Dixon - May 29, 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Wendy L. Dixon
Stock symbol
ZVRA
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/30/2025, 09:40 PM
Previous filing
May 15, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DIXON WENDY L Director C/O ZEVRA THERAPEUTICS, INC., 1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Wendy L. Dixon 2025-05-30 0001202283

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Stock Option (right to buy) Award $0 +30K $0.00 30K May 29, 2025 Common Stock 30K $8.62 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.
F2 This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.
F3 One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.